Project cooperationUpdated on 26 March 2026
Looking for Consortium: Emergency Medicine Research Group
International Project Manager at FINBA
OVIEDO, Spain
About
The Emergency Medicine Research Group at ISPA-FINBA, located at the Central University Hospital of Asturias (HUCA), is a high-capacity clinical research environment within the public healthcare system of the Principality of Asturias (Spain).
Our Emergency Department (ED) manages approximately 140,000 patients annually, providing access to a large, heterogeneous real-world population and early-stage disease presentations. This enables efficient patient recruitment, high-quality prospective data collection, and robust outcome assessment in acute care settings.
What we offer:
-
Strong recruitment capacity for multicenter clinical studies
-
Expertise in real-world evidence generation in emergency settings
-
Experience in prospective data collection and clinical research workflows
-
Access to early-phase patient pathways in acute and urgent care
Collaboration interests:
We are interested in participating as a recruitment center and clinical/scientific partner in European collaborative projects, particularly within the Horizon Europe Cluster Health framework. Our main focus areas include:
-
Cardiovascular diseases in acute care
-
Sex and gender differences in emergency medicine
-
Patient stratification and outcomes in urgent and emergent conditions
We are open to engaging with academic, clinical, and industry partners to strengthen proposals and contribute to high-impact, patient-centered research.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Hospital-based Translational Research & Clinical Trials Partner
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Iacopo Megna
Clinical Project Manager - Grant Officer at University Hospital SS Antonio e Biagio e C. Arrigo
Alessandria, Italy
Project cooperation
VIOSync®: An AI-Driven Clinical Decision Support System for Early Risk Detection and Proactive Care
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
Ioannis Gkouzionis
CEO at Aisthesis Medical
London, United Kingdom
Project cooperation
Integrated Omics–Driven Diagnostic Innovation Laboratory
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Vel Murugan
Professor at AZ Board of Regents on behalf of Arizona State University
Tempe, United States